Pharmacovigilance Industry Overview The global pharmacovigilance market size is expected to reach USD 17.36 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.5% from 2022 to 2030. Increasing incidence of Adverse Drug Reactions (ADRs) is the key growth driver. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug. Pharmacovigilance Market Segmentation Grand View Research has segmented the global pharmacovigilance market on the basis of the product life cycle, service provider, type, process flow, therapeutic area, end-use, and region: Based on the Service Provider Insights, the market is segmented into In-house, Contract Outsourcing.
Based on the Product Life Cycle Insights, the market is segmented into Pre-clinical, Phase I, Phase II, Phase III, Phase IV.
Based on the Type Insights, the market is segmented into Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining.
Based on the Therapeutic Area Insights, the market is segmented into Oncology, Neurology, Cardiology, Respiratory Systems, Others.
Based on the End-use Insights, the market is segmented into Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others.
Pharmacovigilance Regional Outlook
Key Companies Profile & Market Share Insights The market is witnessing a significant boost owing to the patent expiration of branded drugs and the increasing number of new drug developments. This has attracted several local and international pharmacovigilance service providers. The presence of a competitive milieu has led to improved clinical data management and has streamlined the R&D process. Some prominent players in the global pharmacovigilance market include
Order a free sample PDF of the Pharmacovigilance Market Intelligence Study, published by Grand View Research.
0 Comments
COVID-19 Sample Collection Kits Market Is Expected To Expand At A CAGR Of 8.7% From 2022 To 20308/30/2022 COVID-19 Sample Collection Kits Industry Overview The global COVID-19 sample collection kits market size is expected to reach USD 3.03 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.7% from 2022 to 2030. The continuous approval of diagnostic tests for effective diagnoses of SARS-CoV-2 infection raises the demand for sample collection products, such as swabs and Viral Transport Media (VTM). In addition, a shortage of testing materials such as swabs, reagents, and others has resulted in the proliferation of new players in the space, thereby driving the market revenue. COVID-19 Sample Collection Kits Market Segmentation Grand View Research has segmented the global COVID-19 sample collection kits market based on product, application, site of collection, and region: Based on the Product Insights, the market is segmented into Swabs, Viral Transport Media, Blood Collection Kits, Other Consumables.
Based on the Application Insights, the market is segmented into Diagnostics, Research.
Based on the Site of Collection Insights, the market is segmented into Hospitals & Clinics, Home Test.
COVID-19 Sample Collection Kits Regional Outlook
Key Companies Profile & Market Share Insights The presence of a substantial number of well-established, small, and medium-sized players has led to an increase in the market competition. Each player is undertaking multiple business strategies to gain a competitive edge in the market. Some prominent players in the global COVID-19 sample collection kits market include
Order a free sample PDF of the COVID-19 Sample Collection Kits Market Intelligence Study, published by Grand View Research. Clinical Laboratory Service Industry Overview The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. Growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to positively impact the market growth over the forecast period. For instance, according to the WHO, by 2030, cardiovascular diseases are estimated to cause approximately 23.6 million deaths, mainly from heart disease and stroke. Clinical Laboratory Service Market Segmentation Grand View Research has segmented the global clinical laboratory service market on the basis of test type, service provider, application, and region: Based on the Test Type Insights, the market is segmented into Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests.
Based on the Service Provider Insights, the market is segmented into Hospital-Based Laboratories, Stand-Alone Laboratories, Clinic-Based Laboratories.
Based on the Application Insights, the market is segmented into Bioanalytical & Lab Chemistry, Toxicology Testing, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Others.
Clinical Laboratory Service Regional Outlook
Key Companies Profile & Market Share Insights Market entities are undertaking strategic initiatives to address the growing demand for clinical laboratory services. Major players are involved in the acquisition of small players to enhance their services portfolio and improve their geographical presence. Some prominent players in the global clinical laboratory service market include
Order a free sample PDF of the Clinical Laboratory Service Market Intelligence Study, published by Grand View Research. Cancer Biopsy Industry Overview The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 11.13% from 2021 to 2027. The expanding landscape of molecular medicine paved the way for the development of new devices for the molecular characterization of cancers. Thus, increasing adoption and product approvals for liquid biopsies are expected to drive the overall market. Cancer Biopsy Market Segmentation Grand View Research has segmented the global cancer biopsy market on the basis of product, type, application, and region: Based on the Product Insights, the market is segmented into Instruments, Kits and Consumables, Services.
Based on the Application Insights, the market is segmented into Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others.
Based on the Type Insights, the market is segmented into Tissue Biopsies, Liquid Biopsies, Others.
Cancer Biopsy Regional Outlook
Key Companies Profile & Market Share Insights Key players are contributing to market growth by expanding their diagnostics portfolio, further enhancing the uptake of their proprietary biopsy products. For instance, in March 2021, Illumina, Inc. announced medical device registration for its NextSeq 550Dx platform and associated reagent kits in Russia. Some prominent players in the global cancer biopsy market include
Order a free sample PDF of the Cancer Biopsy Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Histology And Cytology Industry Overview The global histology and cytology market size is expected to reach USD 37.10 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.74% from 2021 to 2028. The factors contributing to the market growth include an increase in the demand for the early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy. Histology And Cytology Market Segmentation Grand View Research has segmented the global histology and cytology market on the basis of type of examination, product, application, and region: Based on the Type Of Examination Insights, the market is segmented into Histology, Cytology.
Based on the Product Insights, the market is segmented into Instruments and Analysis Software System, Consumable and Reagents.
Based on the Application Insights, the market is segmented into Drug Discovery & Designing, Clinical Diagnostics, Research.
Histology And Cytology Regional Outlook
Key Companies Profile & Market Share Insights Rapid introduction and approvals attained by different cancer screening pathology solutions have been witnessed in recent years. For instance, in May 2021, Hologic, Inc., received premarket approval from the U.S. FDA for its ThinPrep Genesis Processor. This instrument combines sample aliquoting and cytology processing with improved workflow. Some prominent players in the global histology and cytology market include
Order a free sample PDF of the Histology And Cytology Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. In Vitro Diagnostics Industry Overview The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users. In Vitro Diagnostics Market Segmentation Grand View Research has segmented the global in vitro diagnostics market based on product, technology, application, end-use, test location, and region: Based on the Product Insights, the market is segmented into Instruments, Reagents, Services.
Based on the Technology Insights, the market is segmented into Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, Others.
Based on the Application Insights, the market is segmented into Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Drug Testing, Others.
Based on the End-use Insights, the market is segmented into Hospitals, Laboratories, Home Care, Others.
Based on the Test Location Insights, the market is segmented into Point of Care, Home Care, Others.
In Vitro Diagnostics Regional Outlook
Key Companies Profile & Market Share Insights Market players undertake this strategy to strengthen their product portfolios and offer diverse technologically advanced & innovative products to their customers. In January 2021, Abbott received FDA approval for its rapid handheld Traumatic Brain Injury (TBI) blood test. The first-of-its-kind test is used for assessing mild TBIs and concussions in patients. Some prominent players in the global In vitro diagnostics market include
Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research. C-reactive Protein Testing Industry Overview The global C-reactive protein testing market size is expected to reach USD 5.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 0.3% from 2021 to 2028. The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena. C-reactive Protein Testing Market Segmentation Grand View Research has segmented the global C-reactive protein testing market on the basis of assay type, detection range, disease area, end-use, and region: Based on the Assay Type Insights, the market is segmented into Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others.
Based on the Disease Type Insights, the market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others.
Based on the Detection Range Insights, the market is segmented into hs-CRP, Conventional CRP, cCRP.
Based on the End-use Insights, the market is segmented into Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others.
C-reactive Protein Testing Regional Outlook
Key Companies Profile & Market Share Insights Key market participants are involved in growth strategies to expand their C-reactive protein testing business. For instance, in July 2021, Boditech Med, Inc. announced plans for expansion of its production capacity two-fold. Some prominent players in the global C-reactive protein testing market include:
Order a free sample PDF of the C-reactive Protein Testing Market Intelligence Study, published by Grand View Research. Ophthalmic Drugs Industry Overview The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050. Moreover, due to COVID-19, it has become increasingly unsafe for individuals to touch their face several times a day, which is a known cause of transmission. Therefore, companies are developing long-acting, hands-free therapies to combat such challenges. For instance, in April 2020, Ocular Therapeutix, Inc. completed Phase III clinical trial to evaluate the safety and efficacy of DEXTENZA for allergic conjunctivitis. It is a hands-free therapy administered in the office setting as an intracanalicular insert. It is bioresorbable and designed to release the corticosteroid dexamethasone to the ocular surface, lasting 30 days. It is a one-time and long-acting therapy that can be useful during the COVID-19 crisis. Ophthalmic Drugs Market Segmentation Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region. Based on the Drugs Class Insights, the market is segmented into Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Antiglaucoma, Others.
Based on the Disease Insights, the market is segmented into Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Others.
Based on the Route of Administration Insights, the market is segmented into Topical, Local Ocular, Systemic.
Based on the Product Type Insights, the market is segmented into Prescription Drugs, OTC Drugs.
Based on the Dosage Form Insights, the market is segmented into Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments.
Ophthalmic Drugs Regional Outlook
Key Companies Profile & Market Share Insights Key companies are focusing on the research and development of novel drugs to combat the rising prevalence of eye disorders. For instance, in June 2020, Novartis received label update approval from the U.S. FDA for Beovu (brolucizumab). The update included additional safety information related to retinal vascular occlusion and retinal vasculitis. Some prominent players in the global ophthalmic drugs market include
Order a free sample PDF of the Ophthalmic Drugs Market Intelligence Study, published by Grand View Research. Lateral Flow Assays Industry Overview The global lateral flow assays market size is expected to reach USD 9.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.0% from 2021 to 2028. Major drivers of the market include an increase in the prevalence of infectious diseases, a rise in government initiatives to curb infectious and chronic diseases, a rise in demand for point of care testing, and strategic mergers and acquisitions. Lateral Flow Assays Market Segmentation Grand View Research has segmented the global lateral flow assays market report on the basis of product, application, technique, end use, and region: Based on the Product Insights, the market is segmented into Kits & Reagents, Lateral Flow Readers.
Based on the Application Insights, the market is segmented into Clinical Testing.
Based on the Technique Insights, the market is segmented into Sandwich Assays, Competitive Assays, Multiplex Detection Assays.
Based on the End-use Insights, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical & Biotechnology Companies, Others.
Lateral Flow Assays Regional Outlook
Key Companies Profile & Market Share Insights The market for lateral flow assays is highly competitive with the presence of a large number of key players as well as emerging players in it. The advent of new strategic plans to maintain competitiveness stimulates market growth. The COVID-19 pandemic has resulted in an increasing number of new market entrants, in turn intensifying the market competition. Some prominent players in the global lateral flow assays market include
Order a free sample PDF of the Lateral Flow Assays Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Point Of Care Diagnostics & Testing Industry Overview The global point of care diagnostics market size is expected to reach USD 68.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2022 to 2030. The introduction of advanced technologies such as Telehealth enabled POCT is expected to fuel market growth. Furthermore, the rise in the geriatric population and their need for accessible home-based care are anticipated to drive the market. Point Of Care Diagnostics & Testing Market Segmentation Grand View Research has segmented the global point of care diagnostics market based on product, end-use, and region: Based on the Product Insights, the market is segmented into Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology.
Based on the End-use Insights, the market is segmented into Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory.
Point Of Care Diagnostics & Testing Regional Outlook
Key Companies Profile & Market Share Insights Point-of-care diagnostics has witnessed considerable progress in the past years. Integration of molecular diagnostics in POC testing is one of the significant advancements in this segment. Despite the fact that major players have limited the opportunities for new entrants, some companies were able to mark their entry into the market. Some prominent players in the global point of care diagnostics & testing market include
Order a free sample PDF of the Point Of Care Diagnostics & Testing Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. |
Archives
December 2023
Categories |